Friday, May 1, 2026

North Korea Conducts Hypersonic Missile Drill… Kim Jong-un Vows To Maintain And Expand Nuclear Deterrence

North Korea launched a hypersonic missile, with Kim Jong-un personally overseeing the launch, according to state media reports.

Stock Rallies Worldwide, Could This Be the ‘Powell Effect’?

The U.S. Federal Reserve's decision to maintain...

KPop Demon Hunters: Netflix’s Oscar Nominations for Best Animated Feature and Original Song Revealed!

Netflix's animated series KPop Demon Hunters earns two Oscar nominations, while Park Chan-wook's No Other Choice misses out.

Tag: clinical trials

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

New Obesity Drug Shows Big Promise — and It’s Not from Eli Lilly or Novo

Metsera leads emerging obesity treatments with promising drug MET-233i, showing significant weight loss in trials, amid rising competition.

China Pulls Off Mind-Control Milestone With Brain Chip Trial

China advances brain-computer interface technology with successful trials, enabling paralyzed patients to control devices using thoughts.

New Hope for Solid Tumors? Korean Biotech Starts Phase 1 Trial of Targeted Drug

Digmbio secures 12 billion KRW for clinical trials of cancer drug DM5167 and advances treatment for degenerative brain diseases.

Ozempic Maker Swaps CEO, Bets $2.2B on New Obesity Drug Fight

Novo Nordisk's leadership change aims to reclaim its obesity treatment market share amid competition from Eli Lilly's Mounjaro.

David Sinclair and Irina Conboy Lead Breakthroughs in Age-Reversing Technology

Leading scientists are advancing aging reversal technologies, focusing on gene reprogramming and plasma dilution for potential rejuvenation.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Tumors Shrinking, Hopes Rising: Voronoi’s VRN11 Shows Over 40% Tumor Reduction in Early Lung Cancer Trial

Voronoi's VRN11 shows promising anti-cancer efficacy in early trials, reducing tumors in resistant lung cancer patients without major side effects.

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

ProGen’s PG-110 Targets Fat Loss Without Muscle Waste—Next-Gen Obesity Drug in Focus

ProGen will present non-clinical results of its obesity drug PG-110 at the ADA conference, targeting muscle preservation and weight loss.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.